v3.26.1
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities:      
Net loss $ (327,526) $ (10,206,517) $ (3,546,309)
Forgiveness of unrelated vendor payables   (2,142,297)  
Forgiveness of related party receivables   126,275  
Depreciation   1,828  
Change in fair value of deferred underwriting fee - paid in common stock   196,000  
Change in the fair value of warrant liability 0 54,312 0
Loss on issuance of common stock in connection with the surrendar of warrants   1,740,000  
Fair value of common stock to be issued for contingent liability   7,360,000  
Changes in operating assets and liabilities      
Due from related party, current   (3,427,000)  
Prepaid and other current assets (50,846) 324,609 (133,251)
Accounts payable and accrued expenses 121,467 (4,035,340) (10,747)
Accrued interest, related parties 115,512 215,903 338,882
Accrued maintenance fee     360,000
Due to research and development partner     1,540,359
Due to related party (18,000) (62,467)  
Net cash used in operating activities (159,393) (9,963,318) (1,451,066)
Cash Flows from Investing Activities      
Loans to Iris Acquisition Corp (575,000) (775,000) (2,850,000)
Purchases of property and equipment   (13,108)  
Net cash used in investing activities (575,000) (788,108) (2,850,000)
Cash Flows from Financing Activities:      
Gross proceeds from issuance of common stock for PIPE investment   10,556,500  
Payment of transaction costs   (2,563,738)  
Proceeds from issuance of short-term debt, related party 713,000 4,340,000 3,923,000
Repayment of short-term debt, related party   (1,300,000)  
Net cash provided by financing activities 713,000 11,032,762 3,923,000
Net change in cash (21,393) 281,336 (378,066)
Cash, beginning of the period 56,319 56,319 434,385
Cash, end of the period 34,926 337,655 56,319
Non-cash investing and financing activities:      
Liabilities assumed in connection with the Business Combination   10,694,604  
Fair value of shares to be issued to underwriter on date of the Business Combination   7,049,000  
Transaction costs incurred upon closing of the Business Combination   1,518,381  
Settlement of loans to Iris Acquisition Corp upon closing of the Business Combination   4,443,500  
Issuance of common stock to Iris Acquisition Holdings, LLC   690  
Conversion of related party short-term debt into common stock   14,797,901  
Non-cash conversion of short term debt, related parties for PIPE Funds   3,427,000  
Non-cash impact to APIC for the forgiveness of accrued interest on converted related party debt   169,201  
Issuance of common stock to underwriter   $ 7,245,000  
Deferred transaction costs in accounts payable $ 112,112   $ 561,441